CONMED Corp — Director's Dealing 2023

May 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-04-28

Reporting Person: Pelletier Johonna Marie (Treasurer and VP, Tax)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-28	Common Stock	M	2000	$41.93	Acquired	4634	Direct
2023-04-28	Common Stock	M	5400	$59.96	Acquired	10034	Direct
2023-04-28	Common Stock	M	5400	$78.76	Acquired	15434	Direct
2023-04-28	Common Stock	M	5100	$97.69	Acquired	20534	Direct
2023-04-28	Common Stock	M	4800	$122.55	Acquired	25334	Direct
2023-04-28	Common Stock	S	1317	$127.06	Disposed	24017	Direct
2023-04-28	Common Stock	S	2000	$126.45	Disposed	22017	Direct
2023-04-28	Common Stock	S	5400	$126.43	Disposed	16617	Direct
2023-04-28	Common Stock	S	5400	$126.18	Disposed	11217	Direct
2023-04-28	Common Stock	S	5100	$126.37	Disposed	6117	Direct
2023-04-28	Common Stock	S	4800	$126.33	Disposed	1317	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-28	Options To Purchase Common Stock	$41.93	M	2000	Disposed	2027-03-01	Common Stock (2000)	Direct
2023-04-28	Options To Purchase Common Stock	$59.96	M	5400	Disposed	2028-03-01	Common Stock (5400)	Direct
2023-04-28	Options To Purchase Common Stock	$78.76	M	5400	Disposed	2029-03-01	Common Stock (5400)	Direct
2023-04-28	Options To Purchase Common Stock	$97.69	M	5100	Disposed	2030-03-02	Common Stock (5100)	Direct
2023-04-28	Options To Purchase Common Stock	$122.55	M	4800	Disposed	2031-03-01	Common Stock (4800)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.01 to $127.18. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.44 to $126.63. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.17 to $126.72. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.17 to $126.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.08 to $126.47. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.27 to $126.60. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F7: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

F8: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period